EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 30 October 2025

Clinical trials: Swift EU reforms could make 2026 a turning point

Learn more here.

Building on positive momentum, it’s time to implement centralisation and deliver shorter approval times.

The past year has seen renewed political and industry alignment on how to strengthen Europe’s clinical research ecosystem.

Whisper it: cautious optimism is in the air.

By deepening mutual understanding and highlighting concrete ways to drive innovation, the Accelerating Clinical Trials in the EU (ACT EU), which holds its annual meeting at the European Medicines Agency in Amsterdam this week, is providing a foundation on which to build.

Advancing Estimands in Clinical Trials

Understanding estimands is essential for clinical trial teams. That’s why EFPIA, together with EFSPI (European Federation of Statisticians in the Pharmaceutical Industry), supports the Estimand Implementation Working Group (EIWG), a cross-industry forum to share experiences of implementing the new estimand framework introduced in ICH E9(R1).

Explore here the Estimand Academy for Trial Teams series: it’s designed for anyone working in clinical trials and includes real-world case studies.

Events

IHI Brokerage Event 2025
04 November 2025 (Brussels, Belgium)

If you’re interested in future IHI funding opportunities, the IHI Brokerage Event is the ideal place to network and... Read more

Healthcare Systems in the Face of Climate Change
17 November 2025 (Brussels)

The DULBEA, in partnership with Solidaris, is pleased to invite you to its upcoming International Conference on the... Read more

POLITICO Health Care Summit 2025
18 November 2025 (Brussels, Belgium)

Join us on 18 November during the POLITICO Health Care Summit for the Fireside Chat | Unleashing the Future of Life... Read more

Future-proofing Alzheimer’s care: scaling innovation for a healthier Europe
04 December 2025 (Online)

Explore how new therapies and scalable solutions can transform care pathways and strengthen health systems. Read more

What we are reading

Is vaccination a human right in Europe?
On 29 October 2025 (Vaccines Today)

Members of the European Parliament (MEPs), health experts and advocacy groups want the EU to do more on preventative... Read more

Prize in Economic Sciences 2025: From stagnation to sustained growth
On 21 October 2025 (The Royal Swedish Academy of Sciences )

Over the past 200 years, the world has witnessed more economic growth than ever before. Its foundation is the constant... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu